Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9361 - 9368 of 11454 results
CMS’s Proposed Changes to the MSSP Aim to Grow Two-Sided Risk Models and Modify Processes for Evaluating and Facilitating Care Coordination
December 9, 2014| Advisory| Viewpoint
Update: New Jersey Supreme Court to Address Contractually-Shortened Statute of Limitation Provisions
December 9, 2014| Blog| Viewpoint
More GMO Woes: Another Corn Exporter Sues Syngenta for its Failure to Isolate its GMO Corn
December 8, 2014| Blog| Viewpoint
Privacy Monday: December 8, 2104 - The Twelve Days of Privacy 2014
December 8, 2014| Blog| Viewpoint
After the Deal, is it Still Business as Usual?
December 8, 2014| Blog| Viewpoint
Federal Judge Awards Attorneys’ Fees to Defendant in Dismissed Qui Tam Case, Calls Whistleblower a “Serial Relator”
December 5, 2014| Blog| Viewpoint
Medtronic and Covidien’s Blockbuster Medical Products Merger Clears FTC Antitrust Review with Divestiture
December 5, 2014| Advisory| Viewpoint
News & Press Releases
Mintz is pleased to announce that 31 attorneys have been named Massachusetts Super Lawyers and 35 attorneys have been named Massachusetts Rising Stars for 2024.
Mintz Achieves 2023-2024 Mansfield Certification from Diversity Lab
October 02, 2024
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.